Algert Global LLC Has $3.58 Million Holdings in Oscar Health, Inc. (NYSE:OSCR)

Algert Global LLC boosted its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 46.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 226,339 shares of the company’s stock after buying an additional 71,706 shares during the period. Algert Global LLC owned about 0.10% of Oscar Health worth $3,581,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Avalon Trust Co acquired a new stake in Oscar Health during the 1st quarter worth about $69,000. Point72 Hong Kong Ltd acquired a new stake in Oscar Health during the 2nd quarter worth about $78,000. Quest Partners LLC acquired a new stake in Oscar Health during the 2nd quarter worth about $93,000. Amalgamated Bank raised its holdings in Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the period. Finally, Focus Financial Network Inc. ADV acquired a new stake in Oscar Health during the 4th quarter worth about $152,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several research analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Wells Fargo & Company lifted their target price on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.17.

Oscar Health Trading Up 1.0 %

Shares of NYSE OSCR opened at $21.21 on Tuesday. The stock has a market cap of $5.03 billion, a price-to-earnings ratio of -53.03, a PEG ratio of 43.01 and a beta of 1.61. The business has a 50 day simple moving average of $18.60 and a 200 day simple moving average of $17.89. Oscar Health, Inc. has a 52 week low of $4.72 and a 52 week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. The business had revenue of $2.20 billion during the quarter, compared to analysts’ expectations of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm’s quarterly revenue was up 44.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.07) EPS. On average, research analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In related news, EVP Alessandrea C. Quane sold 16,793 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the sale, the executive vice president now owns 392,607 shares of the company’s stock, valued at approximately $6,697,875.42. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the sale, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the sale, the chief financial officer now directly owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. The disclosure for this sale can be found here. In the last quarter, insiders sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.